Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders
- PMID: 14715844
- DOI: 10.1210/jc.2003-030550
Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders
Abstract
The survival rate of patients with medullary thyroid carcinoma (MTC) is significantly better in patients diagnosed and treated when the tumor is limited to the thyroid. In a pioneer study carried out in 1991, we demonstrated that routine measurement of serum calcitonin (CT) in nodular thyroid disease allowed the preoperative diagnosis of unsuspected sporadic MTC with better accuracy than routine fine needle aspiration cytology (FNAC). This finding has been confirmed in subsequent studies. In the present study we report the results of CT screening in 10,864 patients with thyroid nodular disease seen in the years 1991-1998 (group 1). We analyzed the prevalence of MTC and compared their outcomes with those of a historical group of patients (group 2) diagnosed before the introduction of CT screening (1970-1990). The prevalence of MTC found by CT screening in group 1 was 0.40% (44 patients). A positive CT test had a higher diagnostic sensitivity and specificity compared with FNAC. CT screening allowed the diagnosis of MTC at an earlier stage compared with group 2 (P = 0.004). Normalization of serum CT levels (undetectable) after surgery was more frequently observed in group 1. At the end of follow-up, complete remission was observed in 59% of group 1 and in 2.7% of group 2 (P = 0.0001). Our study confirms that MTC is not an infrequent finding among patients with thyroid nodules (nearly 1 in 250 patients). In addition, screening thyroid nodules with serum CT measurement allows the diagnosis and treatment of MTC at an earlier stage, resulting in a better outcome compared with MTC not detected by serum CT measurement. One of the reasons for this finding is that increasing the preoperative diagnostic accuracy of MTC prompts the surgeon to perform a more radical and possibly curative treatment. On this basis, routine measurement of basal serum CT levels should be considered an integral part of the diagnostic evaluation of thyroid nodules.
Comment in
-
Should serum calcitonin be routinely measured in patients with thyroid nodules--will the law answer before endocrinologists do?J Clin Endocrinol Metab. 2004 Sep;89(9):4768-9; author reply 4769-70. doi: 10.1210/jc.2004-0314. J Clin Endocrinol Metab. 2004. PMID: 15356093 No abstract available.
Similar articles
-
Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.J Clin Endocrinol Metab. 1994 Apr;78(4):826-9. doi: 10.1210/jcem.78.4.8157706. J Clin Endocrinol Metab. 1994. PMID: 8157706
-
Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.Clin Endocrinol (Oxf). 1995 May;42(5):453-60. doi: 10.1111/j.1365-2265.1995.tb02662.x. Clin Endocrinol (Oxf). 1995. PMID: 7621562
-
Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.J Clin Endocrinol Metab. 2007 Feb;92(2):450-5. doi: 10.1210/jc.2006-1590. Epub 2006 Nov 21. J Clin Endocrinol Metab. 2007. PMID: 17119000
-
[Calcitonin determination for early diagnosis of medullary thyroid cancer].Chirurg. 2010 Jul;81(7):620, 622-6. doi: 10.1007/s00104-009-1883-9. Chirurg. 2010. PMID: 20549176 Review. German.
-
Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada.Thyroid. 2011 Nov;21(11):1199-207. doi: 10.1089/thy.2010.0297. Epub 2011 Sep 21. Thyroid. 2011. PMID: 21936671 Review.
Cited by
-
Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.Surgery. 2011 Dec;150(6):1168-77. doi: 10.1016/j.surg.2011.09.043. Surgery. 2011. PMID: 22136837 Free PMC article.
-
Elastographic presentation of medullary thyroid carcinoma.Endocrine. 2014 Feb;45(1):153-5. doi: 10.1007/s12020-013-0062-4. Epub 2013 Sep 25. Endocrine. 2014. PMID: 24065313
-
Sporadic medullary thyroid carcinoma: clinical data from a university hospital.Clinics (Sao Paulo). 2009 May;64(5):379-86. doi: 10.1590/s1807-59322009000500002. Clinics (Sao Paulo). 2009. PMID: 19488601 Free PMC article.
-
Development and application of a novel sensitive immunometric assay for calcitonin in a large cohort of patients with medullary and differentiated thyroid cancer, thyroid nodules, and autoimmune thyroid diseases.Eur Thyroid J. 2014 Jun;3(2):117-24. doi: 10.1159/000363055. Epub 2014 Jun 18. Eur Thyroid J. 2014. PMID: 25114875 Free PMC article.
-
The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology.Bosn J Basic Med Sci. 2022 Feb 1;22(1):118-123. doi: 10.17305/bjbms.2021.5756. Bosn J Basic Med Sci. 2022. PMID: 34247569 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical